An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates

The development of immunogens that elicit broadly reactive neutralising antibodies (bNAbs) is the highest priority for an HIV vaccine. We have shown that a prime-boost vaccination strategy with vaccinia virus expressing the envelope glycoprotein gp120 of HIV-2 and a polypeptide comprising the envelo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taveira, Nuno, Figueiredo, Inês, Calado, Rita, Martin, Francisco, Bártolo, Inês, Marcelino, José M., Borrego, Pedro, Cardoso, Fernando, Barroso, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219247/
https://www.ncbi.nlm.nih.gov/pubmed/37240423
http://dx.doi.org/10.3390/ijms24109077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219247/
https://www.ncbi.nlm.nih.gov/pubmed/37240423
http://dx.doi.org/10.3390/ijms24109077

Ejemplares similares